Enterprise Value
-6.21M
Cash
186.9M
Avg Qtr Burn
-21.4M
Short % of Float
10.16%
Insider Ownership
0.90%
Institutional Own.
90.38%
Qtr Updated
06/30/23
Drug Pipeline
Powered by

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
Drug & Indication | Stage & Event | Catalyst Date |
---|---|---|
Trem-cel (VOR33) Details Acute myeloid leukemia | Phase 1/2 Data readout | |
VCAR33ALLO Details Acute myeloid leukemia | Phase 1/2 Initiation |